open access

Vol 57, No 2 (2023)
Research Paper
Submitted: 2022-08-24
Accepted: 2023-01-03
Published online: 2023-01-18
Get Citation

Cognitive impairment in chronic migraine compared to pseudotumor cerebri

Olga P. Fermo1, Yifan Zhang2, Jiangxia Wang2, Abhay R. Moghekar3
·
Pubmed: 36651470
·
Neurol Neurochir Pol 2023;57(2):189-197.
Affiliations
  1. Mayo Clinic, Jacksonville, Florida, United States
  2. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States
  3. Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

open access

Vol 57, No 2 (2023)
Research papers
Submitted: 2022-08-24
Accepted: 2023-01-03
Published online: 2023-01-18

Abstract

Introduction. We aimed to define the prevalence of objective cognitive impairment in a group of chronic migraineurs, and to define how migraineurs with cognitive impairment differed from those without impairment, and in doing so to compare cognitive impairment in chronic migraine to another chronic headache-related disorder already associated with cognitive impairment (i.e. pseudotumor cerebri syndrome).

Objectives. Cognitive impairment in migraine, especially chronic migraine, has been too little studied. Only a few studies have been done, demonstrating that cognitive impairment exists in chronic migraineurs. It is not known how this compares to other headache-related conditions.

Material and methods. We administered a cognitive battery consisting of the National Adult Reading Test, Mini-Mental Status Examination, Digit Span, Boston Naming Test, Rey Auditory Verbal Learning Test, Trail Making Test, Controlled Oral Word Association, and Category Fluency. Cognitive impairment was defined as mild single-domain with one test score, and mild multi- -domain with two scores more than two standard deviations below the mean for age-, gender-, and education-adjusted norms. The data from this study was compared to our previously published population of patients with pseudotumor cerebri syndrome.

Results. One hundred prospectively recruited patients with chronic migraine were enrolled. Fifty-seven patients had normal cognitive profiles. Forty-three patients demonstrated mild cognitive impairment, and more than half (n = 24) showed impairment in multiple cognitive domains. Migraineurs with multi-domain impairment had higher pain intensity, shorter duration of disease, were taking narcotics, had more impaired vision-related mental health scores, and worse social health scores. We found an association between objective cognitive impairment and subjective perception of impairment only when controlling for pain. We found no associations with depression and topiramate use. The mean composite cognitive Z score was no different in chronic migraineurs and patients with pseudotumor cerebri.

Conclusions and clinical implications. Most chronic migraineurs have normal cognitive profiles, but a large proportion of them do experience mild cognitive impairment, especially in multiple domains. The impairment seen in migraine is similar to that in pseudotumor cerebri syndrome, which has already been associated with mild cognitive impairment. Cognitively impaired migraineurs are different from non-impaired/less impaired migraineurs in several ways, which may be an important factor in influencing their migraine treatment.

Abstract

Introduction. We aimed to define the prevalence of objective cognitive impairment in a group of chronic migraineurs, and to define how migraineurs with cognitive impairment differed from those without impairment, and in doing so to compare cognitive impairment in chronic migraine to another chronic headache-related disorder already associated with cognitive impairment (i.e. pseudotumor cerebri syndrome).

Objectives. Cognitive impairment in migraine, especially chronic migraine, has been too little studied. Only a few studies have been done, demonstrating that cognitive impairment exists in chronic migraineurs. It is not known how this compares to other headache-related conditions.

Material and methods. We administered a cognitive battery consisting of the National Adult Reading Test, Mini-Mental Status Examination, Digit Span, Boston Naming Test, Rey Auditory Verbal Learning Test, Trail Making Test, Controlled Oral Word Association, and Category Fluency. Cognitive impairment was defined as mild single-domain with one test score, and mild multi- -domain with two scores more than two standard deviations below the mean for age-, gender-, and education-adjusted norms. The data from this study was compared to our previously published population of patients with pseudotumor cerebri syndrome.

Results. One hundred prospectively recruited patients with chronic migraine were enrolled. Fifty-seven patients had normal cognitive profiles. Forty-three patients demonstrated mild cognitive impairment, and more than half (n = 24) showed impairment in multiple cognitive domains. Migraineurs with multi-domain impairment had higher pain intensity, shorter duration of disease, were taking narcotics, had more impaired vision-related mental health scores, and worse social health scores. We found an association between objective cognitive impairment and subjective perception of impairment only when controlling for pain. We found no associations with depression and topiramate use. The mean composite cognitive Z score was no different in chronic migraineurs and patients with pseudotumor cerebri.

Conclusions and clinical implications. Most chronic migraineurs have normal cognitive profiles, but a large proportion of them do experience mild cognitive impairment, especially in multiple domains. The impairment seen in migraine is similar to that in pseudotumor cerebri syndrome, which has already been associated with mild cognitive impairment. Cognitively impaired migraineurs are different from non-impaired/less impaired migraineurs in several ways, which may be an important factor in influencing their migraine treatment.

Get Citation

Keywords

migraine, cognition, impairment, pseudotumor cerebri syndrome

About this article
Title

Cognitive impairment in chronic migraine compared to pseudotumor cerebri

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 57, No 2 (2023)

Article type

Research Paper

Pages

189-197

Published online

2023-01-18

Page views

2300

Article views/downloads

629

DOI

10.5603/PJNNS.a2023.0002

Pubmed

36651470

Bibliographic record

Neurol Neurochir Pol 2023;57(2):189-197.

Keywords

migraine
cognition
impairment
pseudotumor cerebri syndrome

Authors

Olga P. Fermo
Yifan Zhang
Jiangxia Wang
Abhay R. Moghekar

References (39)
  1. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011; 93(3): 385–404.
  2. Gil-Gouveia R, Martins I. Clinical description of attack-related cognitive symptoms in migraine: A systematic review. Cephalalgia. 2017; 38(7): 1335–1350.
  3. Gil-Gouveia R, Oliveira AG, Martins IP. Assessment of cognitive dysfunction during migraine attacks: a systematic review. J Neurol. 2015; 262(3): 654–665.
  4. Gil-Gouveia R, Martins IP. Cognition and cognitive impairment in migraine. Curr Pain Headache Rep. 2019; 23(11): 84.
  5. Huang L, Juan Dong H, Wang Xi, et al. Duration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event-related potentials. J Headache Pain. 2017; 18(1): 54.
  6. Latysheva N, Filatova E, Osipova D, et al. Cognitive impairment in chronic migraine: a cross-sectional study in a clinic-based sample. Arq Neuropsiquiatr. 2020; 78(3): 133–138.
  7. Friedman DI, Quiros PA, Subramanian PS, et al. and the NORDIC IIHTT Study Group. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017; 57(8): 1195–1205.
  8. Sørensen PS, Thomsen AM, Gjerris F. Persistent disturbances of cognitive functions in patients with pseudotumor cerebri. Acta Neurol Scand. 1986; 73(3): 264–268.
  9. Kharkar S, Hernandez R, Batra S, et al. Cognitive impairment in patients with pseudotumor cerebri syndrome. Behav Neurol. 2011; 24(2): 143–148.
  10. Kaplan CP, Miner ME, McGregor JM. Pseudotumour cerebri: risk for cognitive impairment? Brain Inj. 1997; 11(4): 293–303.
  11. Yri HM, Fagerlund B, Forchhammer HB, et al. Cognitive function in idiopathic intracranial hypertension: a prospective case-control study. BMJ Open. 2014; 4(4): e004376.
  12. Arseni C, Simoca I, Jipescu I, et al. Pseudotumor cerebri: risk factors, clinical course, prognostic criteria. Rom J Neurol Psychiatry. 1992; 30(2): 115–132.
  13. Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015; 35(1): 26–30.
  14. Fermo OP, Rao A, Schwartzbaum A, et al. Predictors of cognitive impairment in pseudotumor cerebri. Neurol Neurochir Pol. 2021; 55(4): 394–402.
  15. Ferreira KS, Teixeira CT, Cáfaro C, et al. Chronic migraine patients show cognitive impairment in an extended neuropsychological assessment. Arq Neuropsiquiatr. 2018; 76(9): 582–587.
  16. eadache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalagia. 2013; 33(9): 629–808.
  17. Lo Buono V, Bonanno L, Corallo F, et al. Cognitive functions and psychological symptoms in migraine: a study on patients with and without aura. Int J Neurosci. 2019; 129(6): 588–592.
  18. Minen MT, Begasse De Dhaem O, Kroon Van Diest A, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016; 87(7): 741–749.
  19. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003; 12(8): 963–974.
  20. Chung F, Yegneswaran B, Liao Pu, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008; 108(5): 812–821.
  21. Crawford JR, Smith G, Maylor EA, et al. The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory. 2003; 11(3): 261–275.
  22. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998; 116(11): 1496–1504.
  23. NINDS User Manual. NINDS User Manual Quality of Life in Neurological Disorders (Neuro-QoL) Measures. Version 2.0. March 2015. https://www.sralab.org/sites/default/files/2017-06/Neuro-QOL_User_Manual_v2_24Mar2015.pdf (24.07.2022).
  24. Crawford JR, Moore JW, Cameron IM. Verbal fluency: a NART-based equation for the estimation of premorbid performance. Br J Clin Psychol. 1992; 31(3): 327–329.
  25. Weschler D. WMS-III administration and scoring manual. San Antonio, TX: The Psychological Corportation/Harcourt Brace & Co; 1997.
  26. Tombaugh TN, Hubley AM. The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years. J Clin Exp Neuropsychol. 1997; 19(6): 922–932.
  27. Savage RM, Gouvier WD. Rey Auditory-Verbal Learning Test: the effects of age and gender, and norms for delayed recall and story recognition trials. Arch Clin Neuropsychol. 1992; 7(5): 407–414.
  28. Tombaugh T. Trail making test A and B: normative data stratified by age and education. Archives of Clinical Neuropsychology. 2004; 19(2): 203–214.
  29. Ross TP, Furr AE, Carter SE, et al. The psychometric equivalence of two alternate forms of the Controlled Oral Word Association Test. Clin Neuropsychol. 2006; 20(3): 414–431.
  30. Acevedo A, Loewenstein DA, Barker WW, et al. Category fluency test: normative data for English- and Spanish-speaking elderly. J Int Neuropsychol Soc. 2000; 6(7): 760–769.
  31. Donohue MC, Sperling RA, Salmon DP, et al. Australian Imaging, Biomarkers, and Lifestyle Flagship Study of Ageing, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Cooperative Study. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014; 71(8): 961–970.
  32. Rist PM, Kurth T. Migraine and cognitive decline: a topical review. Headache: The Journal of Head and Face Pain. 2013; 53(4): 589–598.
  33. Schwedt TJ, Chiang CC, Chong CD, et al. Functional MRI of migraine. Lancet Neurol. 2015; 14(1): 81–91.
  34. Maleki N, Becerra L, Brawn J, et al. Common hippocampal structural and functional changes in migraine. Brain Struct Funct. 2013; 218(4): 903–912.
  35. Rościszewska-Żukowska I, Zając-Mnich M, Janik P. Characteristics and clinical correlates of white matter changes in brain magnetic resonance of migraine females. Neurol Neurochir Pol. 2018; 52(6): 695–703.
  36. Hanson LL, Ahmed Z, Katz BJ, et al. Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life. Headache. 2018; 58(7): 1007–1013.
  37. Ozudogru S, Neufeld A, Katz BJ, et al. Reduced visual quality of life associated with migraine is most closely correlated with symptoms of dry eye. Headache. 2019; 59(10): 1714–1721.
  38. Domitrz I, Lipa A, Rożniecki J, et al. Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies. Neurol Neurochir Pol. 2020; 54(4): 337–343.
  39. Domitrz I, Sławek J, Słowik A, et al. Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine. Neurol Neurochir Pol. 2022; 56(1): 39–47.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl